16
Oct
Medtronic plc, a global leader in medical technology, on Tuesday launched its next-generation Avalus Ultra™ Bioprosthesis surgical aortic heart valve in India, aiming to enhance cardiac care for patients nationwide. Building on the decade-long clinical experience of the Avalus™ platform, the Avalus Ultra valve is designed for ease of implantation, durability, and reliable performance, including support for future transcatheter aortic valve-in-surgical aortic valve (TAV-in-SAV) procedures. The low-profile valve accommodates diverse patient anatomies, featuring a flexible sewing cuff for secure placement with minimal paravalvular leak rates. Platinum-iridium coils and tantalum badges improve fluoroscopic visibility during reinterventions, ensuring accurate positioning. The device…
